Baird Medical Investment Holdings (BDMD) Raw Materials (2023 - 2025)

Baird Medical Investment Holdings (BDMD) has reported Raw Materials for 3 consecutive years, with $374738.0 the latest figure, recorded in Q4 2025.

• On a quarterly basis, Raw Materials rose 7.4% year-over-year to $374738.0 in Q4 2025; TTM through Dec 2025 was $374738.0, a 7.4% increase from a year earlier, with the FY2025 full-year figure at $374738.0, up 7.4% from the prior year.
• Raw Materials was $374738.0 for Q4 2025 at Baird Medical Investment Holdings, down from $411192.0 in the prior quarter.
• Over five years, Raw Materials peaked at $516346.0 in Q4 2023 and troughed at $348910.0 in Q4 2024.
• A 3-year average of $412796.5 and a median of $392965.0 in 2025 frame the typical range for Raw Materials.
• Across the five-year window, Raw Materials sank 32.43% in 2024 and climbed 7.4% in 2025, its largest moves.
• Over 3 years, Raw Materials stood at $516346.0 in 2023, then plunged by 32.43% to $348910.0 in 2024, then increased by 7.4% to $374738.0 in 2025.
• The last three Raw Materials figures came in at $374738.0 (Q4 2025), $411192.0 (Q2 2025), and $348910.0 (Q4 2024), per Business Quant data.